Nowadays, PD-1/PD-L1 checkpoint is the most common immunecheckpoint axis observed in NPC, with up to 80% of NPC are observed with PD-L1 expression [375–378]. This evidence concerns the gene PDCD1 and nasopharyngeal carcinoma.